Fibroblast Growth Factor 23 and Risk of Hospitalization with Infection in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fibroblast Growth Factor 23 and Risk of Hospitalization with Infection in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study
Authors
Keywords
-
Journal
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Volume 31, Issue 8, Pages 1836-1846
Publisher
American Society of Nephrology (ASN)
Online
2020-06-24
DOI
10.1681/asn.2019101106
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biomarkers of Mineral and Bone Metabolism and 20-Year Risk of Hospitalization With Infection: The Atherosclerosis Risk in Communities Study
- (2017) Junichi Ishigami et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- FGF23 signaling impairs neutrophil recruitment and host defense during CKD
- (2016) Jan Rossaint et al. JOURNAL OF CLINICAL INVESTIGATION
- Fibroblast Growth Factor 23 and the Risk of Infection-Related Hospitalization in Older Adults
- (2016) Kristen L. Nowak et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production
- (2016) Valentin David et al. KIDNEY INTERNATIONAL
- Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease
- (2016) Saurav Singh et al. KIDNEY INTERNATIONAL
- Associations of FGF23 With Change in Bone Mineral Density and Fracture Risk in Older Individuals
- (2015) Tamara Isakova et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Low Vitamin D and High Fibroblast Growth Factor 23 Serum Levels Associate with Infectious and Cardiac Deaths in the HEMO Study
- (2015) M. Chonchol et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Regulation of FGF23 expression in IDG-SW3 osteocytes and human bone by pro-inflammatory stimuli
- (2015) Nobuaki Ito et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia
- (2014) Thomas O. Carpenter et al. JOURNAL OF CLINICAL INVESTIGATION
- FGF23 Modifies the Relationship Between Vitamin D and Cardiac Remodeling
- (2013) Bonnie Ky et al. Circulation-Heart Failure
- Fibroblast Growth Factor-23 and Cardiovascular Events in CKD
- (2013) J. J. Scialla et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Systematic Review of Validation Studies of the Use of Administrative Data to Identify Serious Infections
- (2013) Claire Barber et al. ARTHRITIS CARE & RESEARCH
- Combined Use of Vitamin D Status and FGF23 for Risk Stratification of Renal Outcome
- (2012) C. Nakano et al. Clinical Journal of the American Society of Nephrology
- Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25-dihydroxyvitamin D in human monocytes
- (2012) Justine Bacchetta et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Biological Variability of Plasma Intact and C-Terminal FGF23 Measurements
- (2012) Edward R. Smith et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- FGF23 neutralization improves chronic kidney disease–associated hyperparathyroidism yet increases mortality
- (2012) Victoria Shalhoub et al. JOURNAL OF CLINICAL INVESTIGATION
- Update on fibroblast growth factor 23 in chronic kidney disease
- (2012) Myles Wolf KIDNEY INTERNATIONAL
- Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C
- (2012) Lesley A. Inker et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Risk of Infection-Related Hospitalization With Decreased Kidney Function
- (2011) Lorien S. Dalrymple et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Instability of fibroblast growth factor-23 (FGF-23): Implications for clinical studies
- (2011) Edward R. Smith et al. CLINICA CHIMICA ACTA
- Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
- (2011) Tamara Isakova JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
- (2011) Tamara Isakova et al. KIDNEY INTERNATIONAL
- Infection-Related Hospitalizations in Older Patients With ESRD
- (2010) Lorien S. Dalrymple et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Infectious Disease Hospitalizations in the United States
- (2009) Krista L. Yorita Christensen et al. CLINICAL INFECTIOUS DISEASES
- Risk of Bloodstream Infection in Patients With Chronic Kidney Disease Not Treated With Dialysis
- (2008) Matthew T. James ARCHIVES OF INTERNAL MEDICINE
- Serum Phosphate Levels and Risk of Infection in Incident Dialysis Patients
- (2008) L. C. Plantinga et al. Clinical Journal of the American Society of Nephrology
- Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
- (2008) Orlando M. Gutiérrez et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now